ENGLEWOOD, Colo., June 9, 2022 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of…
Related Articles
New AJPC Study Examines How PREVENT Equations Translate Cardiovascular Risk Factors into Predicted CVD Risk
BOULDER, Colo., March 13, 2026 /PRNewswire/ — The American Journal of Preventive Cardiology (AJPC) announced the publication of a new study, “Systematic Examination of the PREVENT Equations for Cardiovascular Disease Risk”, examining how the American […]
Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026
Gosselies, Belgium, May 05, 2026 (GLOBE NEWSWIRE) — Gosselies, Belgium, May 5, 2026 – Neuvasq Biotechnologies (“Neuvasq”), a biotechnology company dedicated to advancing first-in-class disease modifying multispecific antibodies designed to repair neurovascular barriers in patients […]
Protected: Colorado’s Life Sciences Community Raises $1.2 Billion in First Two Quarters of 2024
This content is password protected. To view it please enter your password below: Password: The post Protected: Colorado’s Life Sciences Community Raises $1.2 Billion in First Two Quarters of 2024 appeared first on Colorado Bioscience […]
